美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=STELAZINE
符合检索条件的记录共6
1 页 当前第 1 页  返回检索页
1药品名称STELAZINE
申请号011552产品号001
活性成分TRIFLUOPERAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 1MG BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
2药品名称STELAZINE
申请号011552产品号002
活性成分TRIFLUOPERAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
3药品名称STELAZINE
申请号011552产品号003
活性成分TRIFLUOPERAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 5MG BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
4药品名称STELAZINE
申请号011552产品号004
活性成分TRIFLUOPERAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
5药品名称STELAZINE
申请号011552产品号005
活性成分TRIFLUOPERAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格EQ 2MG BASE/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
6药品名称STELAZINE
申请号011552产品号006
活性成分TRIFLUOPERAZINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CONCENTRATE;ORAL规格EQ 10MG BASE/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE